Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107167894 | 10716789 | 4 | F | 20141216 | 20160919 | 20150116 | 20160928 | EXP | CA-OTSUKA-US-2015-10097 | OTSUKA | 18.76 | YR | F | Y | 45.00000 | KG | 20160928 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107167894 | 10716789 | 1 | PS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Intramuscular | 400 MG, UNK | 202971 | 400 | MG | SUSPENSION FOR INJECTION | |||||||
| 107167894 | 10716789 | 2 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Intramuscular | 400 MG, UNK | 202971 | 400 | MG | SUSPENSION FOR INJECTION | |||||||
| 107167894 | 10716789 | 3 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Intramuscular | UNK | 0 | INJECTION | |||||||||
| 107167894 | 10716789 | 4 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Intramuscular | UNK | 0 | INJECTION | |||||||||
| 107167894 | 10716789 | 5 | C | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 20 MG, QD | 1320 | MG | 0 | 20 | MG | QD | |||||
| 107167894 | 10716789 | 6 | C | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 10 MG, QD | 1320 | MG | 0 | 10 | MG | QD | |||||
| 107167894 | 10716789 | 7 | C | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 10 MG, QD | 1320 | MG | 0 | 10 | MG | QD | |||||
| 107167894 | 10716789 | 8 | C | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 20 MG, QD | 1320 | MG | 0 | 20 | MG | QD | |||||
| 107167894 | 10716789 | 9 | C | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 10 MG, QD | 1320 | MG | 0 | 10 | MG | QD | |||||
| 107167894 | 10716789 | 10 | C | ABILIFY | ARIPIPRAZOLE | 1 | UNK | 1320 | MG | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107167894 | 10716789 | 1 | Schizophrenia |
| 107167894 | 10716789 | 3 | Schizophrenia |
| 107167894 | 10716789 | 5 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107167894 | 10716789 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107167894 | 10716789 | Psychotic disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107167894 | 10716789 | 1 | 20141003 | 0 | ||
| 107167894 | 10716789 | 2 | 20141219 | 0 | ||
| 107167894 | 10716789 | 3 | 20141003 | 0 | ||
| 107167894 | 10716789 | 4 | 20141219 | 0 | ||
| 107167894 | 10716789 | 5 | 20140820 | 20141017 | 0 | |
| 107167894 | 10716789 | 6 | 20141018 | 20141031 | 0 | |
| 107167894 | 10716789 | 7 | 20141218 | 20141218 | 0 | |
| 107167894 | 10716789 | 8 | 20141219 | 20150101 | 0 | |
| 107167894 | 10716789 | 9 | 20150102 | 20150115 | 0 |